SBP

SBP GROUP 01177.HK (SBP) Stock Price

Closed
SBP
$0.70
-$0.01(-1.08%)

Content updated: 2026-11-16 17:01:40

Yesterday's Close
$0.71
Today's Open
$0.70
Today's High
$0.71
Today's Low
$0.69
Volume
352.73M shares
52-Week Range
$0.53-$0.93

As of 2026-11-16 17:01:40, SBP GROUP 01177.HK (SBP) was quoted at $0.70, a change of -$0.01 (-1.08%) from the previous close. The day's range was $0.69–$0.71, and the 52-week range was $0.53–$0.93.

Past 1W-1.43%Period Low $0.69Period High $0.72
Past 1M+4.95%Period Low $0.60Period High $0.73
Past 3M+15.27%Period Low $0.60Period High $0.76
Past 1Y-25.84%Period Low $0.53Period High $0.95

About SBP GROUP 01177.HK (SBP)

Sino Biopharmaceutical Limited (“the Company” or “Sino Biopharmaceutical”) and its subsidiaries (“the Group”) are a leading innovation- and R&D-driven pharmaceutical group in China, with operations spanning the entire value chain from drug development and smart manufacturing to commercial sales. Its products cover a wide range of biologic and chemical drugs, and the Group holds leading positions in four core therapeutic areas: oncology, liver disease/cardiovascular and metabolic diseases, respiratory diseases/autoimmune diseases, and surgery/analgesia. The Company was listed on the Hong Kong Stock Exchange in 2000; in 2013, it was selected as a constituent stock of the China Index in the MSCI Global Standard Indexes; in 2018, it was selected as a constituent stock of the Hang Seng Index; and in 2020, it was selected as a constituent stock of the Hang Seng Shanghai-Shenzhen-Hong Kong Stock Connect Biotechnology 50 Index and the Hang Seng China (Hong Kong-listed) 25 Index. It was listed among the “Global Pharma Top 50” published by the authoritative U.S. magazine Pharmaceutical Executive for seven consecutive years, and was named one of Forbes Asia’s “50 Best Companies in the Asia-Pacific” for three consecutive years. The Group’s companies are located in Beijing, Shanghai, Nanjing, Lianyungang, and other locations, and it owns multiple pharmaceutical production bases. Since its establishment, the Group has continued to achieve outstanding results and steady growth. Its core member companies include Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (“Chia Tai Tianqing”), Beijing Tide Pharmaceutical Co., Ltd. (“Beijing Tide”), Laekna Therapeutics (Shanghai) Co., Ltd. (“Laekna”), Hangzhou Hegia Biopharmaceutical Co., Ltd. (“Hegia”), Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (“Nanjing Tianqing”), Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. (“Chia Tai Qingjiang”), Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (“Chia Tai Fenghai”), and invoX Pharma Limited (“invoX”). Guided by its mission of “Health Technology, Bringing Warmth to More Lives,” Sino Biopharmaceutical focuses on innovation, serves patients, and is committed to becoming a leading global pharmaceutical company.
Ticker / Exchanges
SBP / --
Industry / Sector
-- / --
CEO
--
Headquarters
--
Official Website
http://www.sbpgroup.com
Listing Date
--

Recent Company Events

  • 2026-09-01
    Dividend · PaidDividend per share is $0.009, with a payment date of 2026-09-24.

SBP GROUP 01177.HK (SBP) Derivatives Trading

SINO BIOPHARMTrade
Stocks

Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.

CFD

Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.

SBPUSDTTrade
Perpetual Futures

Contracts based on stock prices, with no expiration date. They support 24/7 long, short, and leveraged trading without holding the underlying shares. Be aware of funding fees and liquidation risk.

SBP GROUP 01177.HK (SBP) Company Financials

Valuation and Shares

Market Cap
$13.12B
P/E Ratio (TTM)
37.48
P/B Ratio
2.74
Shares Outstanding
18.68B shares
Float Shares
18.68B shares
Dividend Yield (TTM)
2.18%

Latest Reported Financials

2021 Q1 Financials

Report Release Date: --

Operating Revenue (Actual)

$1.08B

Same Period Last Year: +16.41%

Earnings per Share (Actual)

$0.01

Same Period Last Year: +118.66%

Financials · Actuals

Actual Value2022-FY2023-FY2024-FY2025-FY
Revenue$3.89B$3.92B$4.32B$4.76B
Net Profit$749.07M$763.26M$953.02M$795.77M
Operating Cash Flow$938.12M$908.26M$990.52M$1.39B

SBP FAQ

What is the current stock price of SBP GROUP 01177.HK (SBP)?

x
As of 2026-11-16 17:01 (UTC+8), the latest available quote for SBP GROUP 01177.HK (SBP) is $0.70 USD, with a change of -$0.01 USD (-1.08%) from the previous trading day's close. Current market status: Closed.

How has SBP GROUP 01177.HK stock performed over the past month?

x

What is the market cap of SBP GROUP 01177.HK?

x

What are SBP GROUP 01177.HK's latest financial results?

x

What factors may affect the stock price of SBP GROUP 01177.HK (SBP)?

x

Other Trading Markets

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.